By expenditures
| Name | Title | Type |
|---|---|---|
| Alyssa Simard | Managing Director | Auditee |
| Nick Riso | Director of Finance | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 371198 | 2024 | 2025-10-23 | CBIZ CPAS PC | $2.87M |
| 363863 | 2023 | 2025-08-07 | Cbiz CPAS PC | $2.88M |
| 349473 | 2022 | 2025-03-28 | Cbiz CPAS PC | $2.82M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 371198 | 2024 | 2025-10-23 | 1161279 | 2024-002 | Material Weakness | Yes | L |
| 371198 | 2024 | 2025-10-23 | 1161278 | 2024-002 | Material Weakness | Yes | L |
| 371198 | 2024 | 2025-10-23 | 1161277 | 2024-001 | Material Weakness | Yes | M |
| 371198 | 2024 | 2025-10-23 | 1161276 | 2024-001 | Material Weakness | Yes | M |
| 371198 | 2024 | 2025-10-23 | 1161275 | 2024-001 | Material Weakness | Yes | M |
| 363863 | 2023 | 2025-08-07 | 1149443 | 2023-002 | Significant Deficiency | Yes | I |
| 363863 | 2023 | 2025-08-07 | 1149442 | 2023-002 | Significant Deficiency | Yes | I |
| 363863 | 2023 | 2025-08-07 | 1149441 | 2023-001 | Significant Deficiency | Yes | M |
| 363863 | 2023 | 2025-08-07 | 1149440 | 2023-001 | Significant Deficiency | Yes | M |
| 363863 | 2023 | 2025-08-07 | 573001 | 2023-002 | Significant Deficiency | Yes | I |
| 363863 | 2023 | 2025-08-07 | 573000 | 2023-002 | Significant Deficiency | Yes | I |
| 363863 | 2023 | 2025-08-07 | 572999 | 2023-001 | Significant Deficiency | Yes | M |
| 363863 | 2023 | 2025-08-07 | 572998 | 2023-001 | Significant Deficiency | Yes | M |
| 349473 | 2022 | 2025-03-28 | 1115209 | 2022-005 | Significant Deficiency | - | C |
| 349473 | 2022 | 2025-03-28 | 1115208 | 2022-005 | Significant Deficiency | - | BC |
| 349473 | 2022 | 2025-03-28 | 1115207 | 2022-004 | Significant Deficiency | - | I |
| 349473 | 2022 | 2025-03-28 | 1115206 | 2022-004 | Significant Deficiency | - | I |
| 349473 | 2022 | 2025-03-28 | 1115205 | 2022-003 | Significant Deficiency | - | B |
| 349473 | 2022 | 2025-03-28 | 1115204 | 2022-003 | Significant Deficiency | - | B |
| 349473 | 2022 | 2025-03-28 | 1115203 | 2022-002 | Significant Deficiency | - | ABCIM |
| 349473 | 2022 | 2025-03-28 | 1115202 | 2022-002 | Significant Deficiency | - | ABCIM |
| 349473 | 2022 | 2025-03-28 | 538767 | 2022-005 | Significant Deficiency | - | C |
| 349473 | 2022 | 2025-03-28 | 538766 | 2022-005 | Significant Deficiency | - | BC |
| 349473 | 2022 | 2025-03-28 | 538765 | 2022-004 | Significant Deficiency | - | I |
| 349473 | 2022 | 2025-03-28 | 538764 | 2022-004 | Significant Deficiency | - | I |
| 349473 | 2022 | 2025-03-28 | 538763 | 2022-003 | Significant Deficiency | - | B |
| 349473 | 2022 | 2025-03-28 | 538762 | 2022-003 | Significant Deficiency | - | B |
| 349473 | 2022 | 2025-03-28 | 538761 | 2022-002 | Significant Deficiency | - | ABCIM |
| 349473 | 2022 | 2025-03-28 | 538760 | 2022-002 | Significant Deficiency | - | ABCIM |